Liebe Besucherinnen und Besucher,
aufgrund unseres Sommerfestes sind wir am 03. September 2026 bis 14 Uhr erreichbar. Am 04. September 2026 sind wir wieder wie gewohnt für Sie da. Vielen Dank für Ihr Verständnis.
Ihr Team von Sack Fachmedien
Buch, Englisch, 850 Seiten, Format (B × H): 216 mm x 280 mm, Gewicht: 2960 g
Buch, Englisch, 850 Seiten, Format (B × H): 216 mm x 280 mm, Gewicht: 2960 g
ISBN: 978-1-138-30123-8
Verlag: CRC Press
This comprehensive reference provides an overview of the general principles of cancer staging, as well as specific discussions of each tumour type across the body, including lymphoma and haematological malignancies. For each tumour, the pattern of disease involvement and disease spread are emphasized, the state-of-the-art imaging features surveyed, and the latest tumour staging and methods to assess treatment response are addressed. Separate sections discuss metastatic disease and the effects of treatment on normal and diseased tissues. The final section of the book highlights emerging functional and molecular imaging techniques to evaluate the different biological hallmarks of cancer.
Zielgruppe
Academic and Professional Reference
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizin, Gesundheit: Sachbuch, Ratgeber
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pflege Fachpflege
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Nuklearmedizin, PET, Radiotherapie
Weitere Infos & Material
PART I: PRIMARY TUMOUR EVALUATION AND STAGING. Tumours of the oral cavity and pharynx. Paranasal sinus and nasal cavity neoplasms. Laryngeal tumours. Thyroid cancer. Mediastinal tumours. Lung cancer. Pleural tumours. Breast cancer. Oesophageal cancer. Gastric cancer. Primary tumours of the liver and biliary tract. Pancreatic malignancy. Renal cancer. Primary adrenal malignancy. Primary retroperitoneal tumours. Bladder cancer. Prostate cancer. Testicular cancer. Ovarian cancer. Cervical and uterine tumours. Colorectal cancer. Primary bone tumours. Soft tissue sarcomas. Neuroendocrine tumours. PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY. Lymphoma. Multiple myeloma. PART III: METASTASES. Brain metastases. Lymph node metastases. Lung and pleural metastases. Bone metastases. Liver and spleen metastases. Adrenal metastases. Peritoneal metastases. PART IV: DISEASE RESPONSE AND TREATMENT. Assessment of response to treatment. Tumour-specific disease response criteria. Immunotherapy response. PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS. Oncological effects on the central nervous system. Effects of treatment on the thorax. Effects of treatment on the abdomen and pelvis. Effects of treatment on bone and bone marrow. PART VI: FUNCTIONAL AND MOLECULAR IMAGING. PET-CT: Principles and clinical applications. Functional imaging and emerging techniques in MRI. Functional imaging and emerging techniques in CT. Non-FDG radionuclide imaging and targeted therapies.





